We explored (1) differences in adiponectin, leptin and resistin levels in MS and how these relate to clinical, disability, and MRI measures, adjusted and unadjusted for BMI and (2) how BMI relates to clinical, disability and MRI measures. This evidence concerns the gene ADIPOQ and myeloid sarcoma.